IPP Bureau
Caplin Point receives EIR from FDA with Zero 483 observations
By IPP Bureau - January 07, 2025
The inspection, which is a routine part of the FDA's regulatory oversight, evaluates compliance with Good Manufacturing Practices and other regulatory requirements.
Sentynl Therapeutics receives USFDA acceptance and priority review of new drug application for CUTX-101 product candidate for treatment of Menkes disease
By IPP Bureau - January 07, 2025
Menkes disease is a rare X-linked recessive pediatric disease caused by gene mutations of the copper transporter ATP7A
Sai Ramana Ponugoti appointed as CEO, ICH of Piramal Pharma
By IPP Bureau - January 07, 2025
Consequent to this appointment, Sarosh Shetty ceases to be Interim CEO of ICH.
Quality not just a measure, a way of life that drives innovation: Renewable Energy Minister Joshi
By IPP Bureau - January 07, 2025
The cornerstone of the quality ecosystem is the implementation of the Quality Control Orders
1.48 lakh new TB cases identified in the first 30 days of TB Mukt Bharat -100 Days Intensified Campaign
By IPP Bureau - January 07, 2025
Nadda chairs Joint Strategy Meeting with Line Ministries for TB Mukt Bharat Abhiyan- 100-Day Intensified Campaign
Nutraceuticals CDMO manufacturer Crius Group to adopt 100% AI-based project implementation
By IPP Bureau - January 07, 2025
NutrifyGenie AI, a leading AI-driven platform, was integral in designing scientifically differentiated formulations for a multinational client
Zydus inks agreement with CVS Caremark to add Zituvio, Zituvimet and Zituvimet XR to its template formulary
By IPP Bureau - January 07, 2025
These three NDAs of Sitagliptin (base) and combination franchise have been approved by the USFDA earlier through the 505(b)(2) route
Japan Health Authority approves Biocon Biologics’ Ustekinumab BS, Biosimilar to J&J's Stelara
By IPP Bureau - January 07, 2025
The biosimilar Ustekinumab has been developed and manufactured by the company
Dr. Jitendra Singh announces CSIR's indigenously developed Paracetamol
By IPP Bureau - January 06, 2025
40th DSIR Foundation Day celebration marks 16 more technology transfers from CSIR to MSMEs
ICMR detects two cases of HMPV in Karnataka through routine surveillance
By IPP Bureau - January 06, 2025
ICMR will continue to track trends in HMPV circulation throughout the year
PM Modi lays foundation stone for new building for Central Ayurveda Research Institute in New Delhi
By IPP Bureau - January 06, 2025
2.92 acre facility will combine tradition and innovation, offering new opportunities for holistic healing, specialized clinics, and skill development to be constructed at a cost of around Rs. 185 crore
Zydus Lifesciences appoints Vikram Shukla as President - Parenteral Operations
By IPP Bureau - January 06, 2025
He has 29+ years’ comprehensive experience in world-class Formulations and API (for US and EU requirements) mainly related to injectables
Cupid secures Rs. 14.91 crore order from Govt. of Tanzania for supply of male condoms
By IPP Bureau - January 05, 2025
The order, part of an international framework agreement is to be executed between February to April, 2025
CDSCO approves Wockhardt’s Mignaf for treatment of community acquired bacterial pneumonia
By IPP Bureau - January 05, 2025
Wockhardt plans to launch Miqnaf in the Indian market in coming few months
Yatharth Hospital acquires hospital in New Delhi
By IPP Bureau - January 05, 2025
The acquired hospital is a well-established hospital based out of Model Town, New Delhi
